Email updates

Keep up to date with the latest news and content from AIDS Research and Therapy and BioMed Central.

Open Access Highly Accessed Short report

Diagnoses, prevalence, and state-based federal spending for HIV prevention and treatment in the United States, 2006–2009

Willie H Oglesby1*, Joseph L Smith2 and Sonia A Alemagno1

Author Affiliations

1 Department of Health Policy & Management, College of Public Health, Kent State University, PO Box 5190, Kent, OH 44242, USA

2 Department of Health Policy & Management, College of Public Health, University of South Florida, 12901 Bruce B. Downs Blvd., Tampa, FL 33612, USA

For all author emails, please log on.

AIDS Research and Therapy 2014, 11:15  doi:10.1186/1742-6405-11-15

Published: 6 June 2014

Abstract

Background

In response to an article published in 2012 by officials at the US Department of Health and Human Services (DHHS), an independent analysis of state-based federal resource allocation for HIV was conducted to determine if the funding accurately reflected diagnosis and prevalence rates.

Methods

Total state-based federal funding for HIV, state-based funding for HIV prevention, and state-based funding for HIV treatment were compared to state-based HIV diagnosis and prevalence rates from 2006-2009.

Results

Total state-based federal funding for HIV and funding for HIV prevention and treatment were highly correlated with HIV diagnosis and prevalence rates during the time horizon of the study; however, correlations between state-based HIV prevention funding and state-based HIV diagnosis rates were lower than the correlations between state-based HIV treatment funding and HIV prevalence.

Conclusions

Our findings suggest that state-based federal resource allocation for HIV prevention and treatment may be better aligned with HIV diagnosis and prevalence rates than previously reported; however resource allocation for HIV prevention is less aligned than funding for HIV treatment signaling the need to reexamine state-based federal funding for HIV prevention.

Keywords:
HIV; Resource allocation; Economic evaluation; HIV treatment; HIV prevention; United States